Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue SUPPL. 3, 1999, Pages 83-89

  Breddin, Hans K ^a  

^a International Institute of Thrombosis and Vascular Diseases   (Germany)

Author keywords

Deep vein thrombosis; Fibrinogen uptake test; General surgery; Low molecular weight heparin; Prophylaxis; Venography

Indexed keywords

ARDEPARIN; CERTOPARIN; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PARNAPARIN; REVIPARIN; TINZAPARIN;

ANTICOAGULANT THERAPY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; GENERAL SURGERY; HUMAN; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR;

DALTEPARIN; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NADROPARIN; SURGICAL PROCEDURES, OPERATIVE; VENOUS THROMBOSIS;

EID: 0032753661     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ockelford PA, Patterson J, Johns AS, et al. A double-blind, randomized, placebo controlled trial of thromboprophylaxis in major elective general surgery using once daily injections of a low molecular weight heparin fragment (Fragmin). Thromb Haemost 1989;62:1046-1049
2. Pezzuoli G, Neri Serneri GO, Settembrini P, et al. Prophylaxis of fatal pulmonary embolism in general surgery using low molecular weight heparin CY 216: A multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). Int Surg 1989;74:205-210
3. Marassi A, Balzano G, Hari G, et al. Prevention of post-operative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY216). Int Surg 1993; 78:166-170
4. Nurmohamed MT, van Riel AM, Henkens MA, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost 1996;75:233-238
5. Valle I, Sola G, Origone A. Controlled clinical study of the efficacy of a new low molecular weight heparin administered subcutaneously to prevent post-operative deep venous thrombosis. Curr Med Res Opin 1988; 11:80-86
6. Bergqvist D, Flordal PA, Friberg B, et al. Thromboprophylaxis with a low molecular weight heparin (tinzaparin) in emergency abdominal surgery. A double-blind multicenter trial. Vasa 1996;25:156-160
7. Baca I, Schneider B, Kohler T, et al. Thromboembolieprophylaxe bei minimal-invasiven Eingriffen und kurzstationärer Behandlung. Chirurg 1997;68:1275-1280
8. Samama M, Bernard P, Bonnardot JP, et al. Low molecular weight heparin compared with unfractionated heparin in pre-vention of postoperative thrombosis. Br J Surg 1988;75: 128-131
9. Gazzaniga GM, Angelini G, Pastorino G, et al. Enoxaparin in thé prevention of deep venous thrombosis after major surgery; multicentric study. Int Surg 1993;78:271-275
10. Nurmohamed MT, Verhaeghe R, Haas S, et al. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep-vein thrombosis in general surgery. Am J Surg 1995;169:567-571
11. McLeod R, Geerts W, Sniderman K, et al. Thromboprophylaxis in colorectal surgery-A randomized trial comparing low dose heparin to enoxaparin (ENG). Haemostasis 1996;26(Suppl 3):A290
12. Bergqvist D for the ENOXACAN study group. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicenter trial with venographic assessment. Br J Surg 1997:84:1099-1103
13. Haas S, Flosbach CM. Antithromboembolic efficacy and safety of enoxaparin in general surgery: German multicentre trial. Eur J Surg 1994:571:37-43
14. Adolf J, Knee H, Roder JD, et al. Prevention of thromboembolism with low molecular weight heparin in abdominal surgery. Dtsch Med Wochenschr 1989;1 14:48-53
15. Kakkar VV. A prospective, randomized double-blind trial of low molecular weight heparin (LMWH) and unfractionated heparin (UFH) in the prevention of venous thrombosis. A multicentre study. Expertise for the German authorities (BGA) 1990
16. Koppenhagen K, Matthes M, Haring R, et al. Prophylaxis of thromboembolism in elective abdominal surgery. Comparison of efficacy and safety of low molecular weight heparin and unfractionated heparin. Munch Med Wochenschr 1990;132: 677-680
17. Koppenhagen K, Adolf J, Matthes M, et al. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Thromb Haemost 1992;67:627-630
18. Heilmann L, Kruck M, Schindler AE. Thrombosis prophylaxis in gynecology: A randomized double-blind study between low molecular weight heparin (LMWH) and unfractionated heparin (UFH). Geburtshiefe Frauenheil 1989;49:803-807
19. Heilmann L, von Tempelhoff GF, Herrle B, et al. Low dose heparin versus low molecular weight heparin as thrombosis prophylaxis in gynecological oncology. Geburtshilfe Frauenheilk 1997:57:1-6
20. Bergqvist D, Burmark US, Frisell J, et al. Low molecular weight heparin once daily compared with conventional low dose heparin twice daily. A prospective double-blind multicentre trial on prevention of post-operative thrombosis. Br J Surg 1986;73: 204-208
21. Koller M, Schoch U, Buchmann P, et al. Low molecular weight heparin (Kabi 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin. Thromb Haemost 1986:56:243-246
22. Bergqvist D, Mätzsch T, Burmark US, et al. Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. Br J Surg 1988:75:888-891
23. Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin versus unfractionated heparin in gynecological surgery. Acta Obstet Gynecol Scand 1988;67: 99-103
24. Fricker JP, Vergnes Y, Schach R, et al. Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 1988:18:561-567
25. Caen JP. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the pre-vention of deep vein thrombosis in general surgery: A French Multicenter Study. Thromb Haemost 1988;59:216-220
26. Hartl P, Brücke P, Dienstl E, Vinazzer H. Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and Fragmin. Thromb Res 1990:57:577-584
27. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight heparin versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993 ;341:259-265
28. Kakkar VV, Murray WJG. Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative venous thromboembolism: A cooperative study. (First part). Br J Surg 1985;72:786-791
29. The EPS Group. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 1988:75:1058-1063
30. Eurin B. Efficiency and tolerance of Nadroparin (CY216) for the prevention of postoperative deep vein thrombosis in patients undergoing general surgery under epidural anesthesia (FR). AnnFrReanim 1994:13:311-317
31. Salcuni PF, Azzarone M, Palazzini E. A new low molecular weight heparin for deep vein thrombosis prevention: Effectiveness in postoperative patients. CurrTherap Res 1988;43:824-831
32. Verardi S, Casciani CU, Nicora E, et al. A mullicenter study on low molecular weight heparin effectiveness in preventing post surgical thrombosis. J Int Angiol 1988;7(Suppl 3):19-24
33. Garcea D, Martuzzi F, Santelmo N, et al. Post-surgical deep vein thrombosis prevention. Evaluation of the risk/benefit ratio of fractionated and unfractionated heparin. Curr Med Res 1992; 12:572-583
34. Limmer J, Ellbriick D, Müller H, et al. Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis. J Clin Invest 1994;72:913-919
35. Kakkar VV, Boeckl O, Boneu B, et al. Efficacy and safety of low molecular weight heparin and standard unfractionated heparin for prophylactic of post-operative venous thromboembolism: European multicenter trial. World J Surg 1997;21:2-9
36. Leizorovicz A, Picolet H, Peyrieux JC, Boissel JP. Prevention of perioperative deep-vein thrombosis in general surgery: A multicentre double-blind study comparing two doses of logiparin and standard heparin. Br J Surg 1991:78:412-416
37. Bara L, Leizorovicz A, Picolet H, Samama M. Correlation between anti Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either logiparin (LMWH), or unfractionated heparin. Thromb Res 1992:65:641-650
38. Kakkar VV, Kakkar S, Sanderson RM, et al. Efficacy and safety of two regimens of low molecular weight heparin fragment (Fragmin) in preventing postoperative venous thromboembolism. Haemostasis 1986; 16(Suppl): 19-24
39. Becchi G, Bonomo GM, Scatarella M, et al. Dose-effect relationship in the prevention of post-surgical thromboembolism by a low molecular weight heparin. Act Therap 1993:19:163-179
40. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 Xal units in 2070 patients. Br J Surg 1995:82:496-501
41. Bounameaux H, Huber O, Khabiri E, et al. Unexpectedly high rate of phlebographic deep venous thrombosis following elective general abdominal surgery among patients given prophylaxis with low molecular weight heparin. Arch Surg 1993;128:326-328
42. Hoffmann R, Largiader F. Die Thromboembolieprophylaxe und der Chirurg-zwei Risikofaktoren der postoperativen Blutung? Aktuelle Chir 1995:30:264-270